Partnership to advance life science professionals in drug discovery 

The European Laboratory Research & Innovation Group (ELRIG) UK has entered into a partnership with SRG to support the advancement of science professionals in their careers. 

The partnership offers ELRIG’s drug discovery community access to career opportunities and provides organisations of all sizes with SRG’s talent solutions to help grow the life science sector. In particular, early career professionals (ECPs) in industry and academia can attend forums and networking events where they can meet and learn the skills needed to help them advance their careers in drug discovery. 

As part of the ELRIG events programme, there are a range of activities designed specifically for ECPs. SRG, powered by Impellam Group,  help life science companies — from start-ups to big pharma — to find, attract and nurture emerging talent, and aim to ensure outstanding career prospects for candidates. Together, ELRIG and SRG will provide support to life science professionals that will allow them to gain a deeper understanding of the industry, select the right career path, and develop the tools needed to progress, while helping the drug discovery industry to flourish. 

Sanj Kumar, CEO, ELRIG UK, said: “ELRIG and SRG have a shared ambition to advance the careers of early-stage professionals in drug discovery. ELRIG will provide the opportunities for ECPs to connect, whilst SRG can help them to expand their skillset and progress in their careers. Building such networks is an imperative as they navigate the myriad of collaboration and career options ahead of them.”  

Andrew Turner, Managing Director, SRG, said: “As technological innovations accelerate, new fields emerge, and competition intensifies, the demand for professionals within STEM industries continues to outpace the available talent pool. Our partnership with ELRIG will focus on talent enablement, and supporting the advancement of science professionals at each stage of their career.” 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free